Where PhDs and companies meet
Menu
Login

Disease mechanisms involved in the muscular comorbidities of two rare genetic diseases

ABG-136275 Thesis topic
2026-03-05 Public funding alone (i.e. government, region, European, international organization research grant)
INSERM
- Auvergne-Rhône-Alpes - France
Disease mechanisms involved in the muscular comorbidities of two rare genetic diseases
  • Biology

Topic description

Defective skeletal muscle function such as generalized hypotonia or muscle weakness is among the first clinical manifestations seen in patients diagnosed with rare genetic disease, but this aspect remains largely overlooked. Indeed, very few studies attempted to understand how the underlying genetic mutations affect multiple tissues, particularly those in which symptoms first become visible in skeletal muscle. It is the ambition of the present PhD project to use a multidisciplinary approach to reveal the underlying myopathic mechanisms through a combination of cellular physiology, live imaging and high-resolution episcopic microscopy (HREM). Addressing this gap has the potential to uncover shared disease mechanisms and offer therapeutic advantages across a wide range of rare genetic disorders.
More specifically, this PhD project will focus on the muscle defects associated with two genes coding for the intermembrane lipid transfer protein VPS13B and the Major Vault Protein (MVP), respectively, responsible for rare diseases associated with muscle function defects in patients at neonatal stages (Montillot et al., 2023; Kretz et al., 2023). Experiments will be achieved using genetically modified mouse models of the two diseases that recapitulate the muscle symptomatology of the patients at the whole organism level. Experiments will aim 1- at characterizing the properties of membrane excitability, Ca2+ signaling and excitation-contraction coupling using a combination of electrophysiology and Ca2+ imaging on isolated muscle fibers (see Schreiber et al., 2025), 2- at complementing these functional data by molecular approaches and by a detailed characterization of the muscle fibers sub-compartments using confocal and super-resolution imaging, 3- at achieving a differential anatomical analysis at the cellular level of the control and diseased muscles using HREM technology (see Amelan et al., 2026). This technique which allows deep-phenotyping using 3D reconstruction of a tissue, down to the cellular level, is in routine use in the co-supervising laboratory on brain preparations, where it is combined with artificial-intelligence tools to segment the investigated structures. The technique will be adapted for the first time to skeletal muscle tissue to identify and quantify pathological abnormalities and to establish genotype-phenotype correlations. This innovative technological development will ultimately offer the perspective to use it to understand a wide variety of other muscle diseases. Overall, this project will contribute to understand the molecular and cellular mechanisms involved in the muscle defects associated with ultra-rare diseases. Ultimately, it could help improve the diagnosis and the stratification and follow-up of patients and open therapeutic perspectives. In addition, the project will allow the development and validation of a novel technology of investigation of muscle properties, based on HREM imaging.

Funding category

Public funding alone (i.e. government, region, European, international organization research grant)

Funding further details

Presentation of host institution and host laboratory

INSERM

The overarching scientific program that ties our teams revolves around the study of the physiopathology of the neuron and the skeletal muscle. We aim at deciphering basic biological mechanisms at the molecular, cell, tissue and organism levels to better understand their alterations in human pathologies to uncover new therapeutic approaches. To reach that goal, our teams combine multiscale, multidisciplinary approaches, taking advantage of the most appropriate models to conduct an ambitious research around three main research axes: (1) Physiology and cell biology of the neuromuscular system, (2) Cellular and molecular neurobiology and (3) Nuclear dynamics.

Candidate's profile

Required: Master’s degree or equivalent in Neuroscience, Physiology, Genetics or Biomedical Sciences

 

Skills:

- Strong background in molecular and cellular biology, neurobiology, or physiology

- Knowledge of RNA biology and gene regulation mechanisms

- Experience with molecular biology techniques

- Basic skills in transcriptomic data analysis and statistics

- Ability to work independently and in a multidisciplinary team

- Excellent written and oral communication skills in English

- Experience with mouse models and developmental biology (desirable)

- Experience in imaging, electrophysiology, or functional phenotyping (a plus)

Partager via
Apply
Close

Vous avez déjà un compte ?

Nouvel utilisateur ?